Schultz joins Teva as Venezuela bites into OTC

2 November 2017 - Deborah Wilkes

Archived

Kare Schultz has now joined Teva as president and chief executive officer, as the Israeli generics giant reported OTC sales down by 20% to USD306 million in the third quarter of 2017. In local currency terms, OTC sales were up by 15%.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: